Showing results (131-140 of 1,143) with videos related to
Sort By:
Pageof 115
European Journal of Biochemistry|April 28, 2000
Fidelity analysis of HIV-1 reverse transcriptase mutants with an altered amino-acid sequence at residues Leu74, Glu89, Tyr115, Tyr183 and Met184H Jonckheere, E De Clercq, J AnnéJournal of Viral Hepatitis|March 16, 2000
Lamivudine, adefovir and tenofovir exhibit long-lasting anti-hepatitis B virus activity in cell cultureC Ying, E De Clercq, J NeytsMedicinal Research Reviews|March 21, 2000
The HIV-1 reverse transcription (RT) process as target for RT inhibitorsH Jonckheere, J Anné, E De ClercqCurrent Opinion in Microbiology|March 6, 1999
New antivirals - mechanism of action and resistance developmentJ Balzarini, L Naesens, E De ClercqVerhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|July 5, 2001
Cidofovir in the treatment of HPV-associated lesionsR Snoeck, G Andrei, E De ClercqAntimicrobial Agents and Chemotherapy|July 1, 1995
Susceptibilities of several drug-resistant herpes simplex virus type 1 strains to alternative antiviral compoundsG Andrei, R Snoeck, E De ClercqJournal of Medical Virology|May 1, 1987
Serum and urine concentrations of oral bromovinyldeoxyuridine in humans as monitored by a bioassay system based on varicella-zoster virus focus inhibitionM Baba, S Shigeta, E De ClercqAntiviral Research|June 1, 2004
In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?G Andrei, E De Clercq, R SnoeckJournal of Steroid Biochemistry|September 1, 1988
Stimulatory effects of antiviral adenosine analogs on steroidogenesis in Leydig cellsG Verhoeven, J Cailleau, E De ClercqArzneimittel-Forschung|March 1, 1989
[Penetration and action of edoxudine in vitro and in vivo]R Kaul, B Hempel, E De ClercqPageof 115